‚މŒŒว‚ฬŒป๓‚ฦŒŸธ(5)

Ž_‰ป•ฯซ LDL ‚ฬ—ีฐ“Iˆำ‹`‚ฦ‘ช’่–@

‰ช@“c@ณ@•F*
@@@@@@@@@@@@@@@@@@@@@@
Oxidized LDL, Clinical Aspects and Measurement Methods

Masahiko OKADA, MD*

It is well recognized that oxidative modification of low-density lipoprotein(LDL) accelerates atherogenesis of the arterial vascular wall. Each of lipid peroxidation products, surface charge, or spectrophotometric patterns is applicable to the evaluation of in vitro oxidation. The lag time may contribute to the evaluation of effect of the lipid lowering and antioxidant drugs. ELISA using monoclonal antibody has the potential for clinical use. However, the applicability is not yet established, because of the different kinds of antibody used.
[Rinsho Byori 50 : 248`253, 2002 ]

*Division of Clinical Preventive Medicine, Niigata University Graduate School of Medical and Dental Science, Niigata 951-8510

yKey Wordszoxidized LDL(Ž_‰ป LDL)Clipid peroxidation(‰฿Ž_‰ปމŽฟ)Csurface charge(•\–ส‰ื“d)Cconjugated dienes(Ž_‰ป‹ค–๐•จ)Cautoantibody against oxidized LDL(RŽ_‰ป LDL ŽฉŒศR‘ฬ)

*VŠƒ‘ๅŠw‘ๅŠw‰@ˆใŽ•Šw‘‡Œค‹†‰ศ—\–hˆใ—รŠw•ช–์(ง951-8510 VŠƒŽsˆฎ’ฌ’ส1-757)

E-mail :okadar@med.niigata-u.ac.jp